VP

Vijay Pratap Singh

Active Director Designated Partner DIN 09804855
DIN 09804855 First appointment Dec 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijay Pratap Singh

Data last updated:

Vijay Pratap Singh is a Designated Partner at Taiyo Pharmaceutical Llp (since 2022). The company operates in Pharma.

DIN 09804855
Primary Designation Designated Partner
Industry Pharma
First Appointment 06 Dec 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Dec 20222021Active

Board colleagues of Vijay Pratap Singh

NameDINCompanyDesignation
Arvind Shyamnarayan Singh10659436Taiyo Pharmaceutical LlpDesignated Partner
Shyam Mohan Shukla09402634Taiyo Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Taiyo Pharmaceutical Llp
Premium access

Shareholding and investment profile for Vijay Pratap Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Pratap Singh

Vijay Pratap Singh currently holds 1 directorship: Taiyo Pharmaceutical Llp (Designated Partner, since 06 Dec 2022).

Vijay Pratap Singh was first appointed on 06 Dec 2022 as Designated Partner at Taiyo Pharmaceutical Llp.

The current boards of Vijay Pratap Singh's companies include Arvind Shyamnarayan Singh (Taiyo Pharmaceutical Llp), Shyam Mohan Shukla (Taiyo Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available